West Pharmaceutical Services/WST

-2.75%
-
1D1W1MYTD1YMAX

About West Pharmaceutical Services

West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates through two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers packaging, containment solutions, and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

Ticker

WST

Sector

Healthcare

Trading on

NYSE

Industry

Medical Equipment & Supplies

CEO

Eric Green

Employees

10,600

Headquarters

Exton, United States

WST Metrics

BasicAdvanced
US$26B
Market cap
46.89
P/E ratio
US$7.58
EPS
1.02
Beta
US$0.78
Dividend rate
0.22%
Dividend yield
US$26B
1.01929
US$415.73
US$310.42
489K
US$0.78
2.611
1.948
2.716
7.692
10.23%
96.048
15.08%
20.84%
17.99%
46.888
8.846
9.685
10.123
78.861
0.23%
0.22%
0.22%
1.56%
5.08%
11.17%
19.94%
5.81%

What the Analysts think about WST

Analyst Ratings

Majority rating from 9 analysts.
Buy

Price Targets

Average projection from 7 analysts.
17.35% upside
High US$470.00
Low US$355.00
US$345.86
Current price
US$405.86
Average price target

WST Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
16.58% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
US$695M
-5%
Net income
US$115M
-15.84%
Profit margin
16.58%
-11.38%

WST Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 23.32%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
US$2.11
US$2.16
US$1.83
US$1.56
-
Expected
US$1.93
US$1.86
US$1.78
US$1.27
US$1.74
Surprise
9.54%
16.36%
2.95%
23.32%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for West Pharmaceutical Services stock?

West Pharmaceutical Services (WST) has a market cap of $26B as of May 20, 2024.

What is the P/E ratio for West Pharmaceutical Services stock?

The price to earnings (P/E) ratio for West Pharmaceutical Services (WST) stock is 46.89 as of May 20, 2024.

Does West Pharmaceutical Services stock pay dividends?

Yes, the West Pharmaceutical Services (WST) stock pays dividends to shareholders. As of May 20, 2024, the dividend rate is $0.78 and the yield is 0.22%. West Pharmaceutical Services has a payout ratio of 10.23% on a trailing twelve-month basis.

When is the next West Pharmaceutical Services dividend payment date?

The next West Pharmaceutical Services (WST) dividend payment is scheduled for August 07, 2024.

What is the beta indicator for West Pharmaceutical Services?

West Pharmaceutical Services (WST) has a beta rating of 1.02. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the West Pharmaceutical Services stock price target?

The target price for West Pharmaceutical Services (WST) stock is $405.86, which is 18.41% above the current price of $342.76. This is an average based on projections from 7 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell West Pharmaceutical Services stock

Buy or sell West Pharmaceutical Services stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing